The American Society for Clinical Oncology’s Annual Meeting for 2025 is, if nothing else, absolutely overwhelming and ...

In 2018, the FDA began an investigation into nitrosamine impurities in drugs that led to high-profile recalls for heartburn ...

Notably, the U.S.’ two primary biopharma trade groups—the Pharmaceutical Research and Manufacturers of America (PhRMA) and ...

On the 30th of last month, the Korea Pharmaceutical and Biological Association held a 'KPBMA Ethics Management Workshop' at ...

East Midlands-based biotechnology company N4 Pharma has formed a new senior leadership team featuring consultants in drug ...

Instil Bio (TIL) has announced the appointment of Jamie Freedman as Chief Medical Officer.  Jamie Freedman is a Hematologist-Oncologist and a highly experienced biopharmaceutical executive.

Pharmaceutical manufacturer Sigachi Industries has announced a 10 per cent final dividend for FY25 after posting a strong Q4 ...

An announcement from Telomir Pharmaceuticals, Inc. ( ($TELO) ) is now available. On June 2, 2025, Telomir Pharmaceuticals announced its ...

Investors need to pay close attention to BioMarin Pharmaceutical stock based on the movements in the options market lately.

The global sales of DNA polymerase are estimated to be worth USD 397.7 million in 2025 and anticipated to reach a value of USD 725.8 million by 2035. Sales are projected to rise at a CAGR of 6.2% over ...